Cargando…

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease

Detalles Bibliográficos
Autores principales:	Gelbenegger, Georg, Jäger, Ulrich, Fillitz, Michael, Schörgenhofer, Christian, Sillaber, Christian, Jilma, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189382/ https://www.ncbi.nlm.nih.gov/pubmed/36322823 http://dx.doi.org/10.1182/bloodadvances.2022008574

Ejemplares similares

Sutimlimab for the Treatment of Cold Agglutinin Disease
por: Berentsen, Sigbjørn
Publicado: (2023)

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
por: Röth, Alexander, et al.
Publicado: (2022)

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results
por: Röth, Alexander, et al.
Publicado: (2022)

P1675: SUTIMLIMAB PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: OPEN-LABEL EXTENSION OF THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

P1486: SERUM BIOMARKERS AS PREDICTORS OF RESPONSE TO SUTIMLIMAB IN COLD AGGLUTININ DISEASE (CAD): A POST-HOC ANALYSIS OF PHASE 3 CARDINAL AND CADENZA STUDY DATA
por: Barcellini, Wilma, et al.
Publicado: (2023)

Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study
por: Röth, Alexander, et al.
Publicado: (2022)

Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up
por: Röth, Alexander, et al.
Publicado: (2023)

Concomitant Use of Sutimlimab and COVID-19 Vaccines in Patients with Cold Agglutinin Disease from the Phase 3 Cardinal and Cadenza Studies
por: Fattizzo, Bruno, et al.
Publicado: (2022)

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
por: Röth, Alexander, et al.
Publicado: (2023)

Cold agglutinin disease: current challenges and future prospects
por: Berentsen, Sigbjørn, et al.
Publicado: (2019)

P1487: CONCOMITANT USE OF SUTIMLIMAB AND COVID-19 VACCINES IN PATIENTS WITH COLD AGGLUTININ DISEASE FROM THE PHASE 3 CARDINAL AND CADENZA STUDIES
por: Fattizzo, Bruno, et al.
Publicado: (2023)

P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396)
por: Röth, A., et al.
Publicado: (2022)

P1532: SUTIMLIMAB AFTER PRIOR RITUXIMAB USE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): POOLED POST-HOC ANALYSES FROM THE CARDINAL AND CADENZA TRIALS
por: Röth, A., et al.
Publicado: (2022)

Bridging the Missing Link with Emicizumab: A Bispecific Antibody for Treatment of Hemophilia A
por: Gelbenegger, Georg, et al.
Publicado: (2020)

Mortality in cold agglutinin disease shows seasonal pattern
por: Hansen, Dennis Lund, et al.
Publicado: (2022)

A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway
por: Bartko, Johann, et al.
Publicado: (2018)

Acute exacerbation of cold agglutinin disease during operation
por: Jeong, Jinyoung, et al.
Publicado: (2013)

High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial Infarction
por: Buchtele, Nina, et al.
Publicado: (2020)

Cold Agglutinin Disease
por: Gabbard, Amy P., et al.
Publicado: (2020)

The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
por: Ay, Cihan, et al.
Publicado: (2022)

The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
por: Kovacevic, Katarina D., et al.
Publicado: (2021)

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
por: Gelbenegger, Georg, et al.
Publicado: (2021)

Cold Agglutinin Disease with Erythrophagocytosis by Neutrophils Occurring During Recovery Phase of Chickenpox
por: Walia, Harpreet, et al.
Publicado: (2013)

Eliminating or Minimizing the Effects of Cold Agglutinins on the Accuracy of Complete Blood Count Results
por: La Gioia, Antonio
Publicado: (2019)

Pembrolizumab-Induced Cold Agglutinin Disease
por: Atiq, Osman, et al.
Publicado: (2020)

Necrosis secondary to cold agglutinin disease
por: Nakagawa, Hiroaki, et al.
Publicado: (2022)

Cold Agglutinin Disease; A Laboratory Challenge
por: Nikousefat, Zahra, et al.
Publicado: (2015)

COVID-19 and Cold Agglutinin Hemolytic Anemia
por: Maslov, Diana V., et al.
Publicado: (2020)

Tozinameran: Cold agglutinin disease: case report
Publicado: (2022)

Correspondence: Response to “Eliminating or Minimizing the Effects of Cold Agglutinins on the Accuracy of Complete Blood Count Results”
por: Rim, John Hoon, et al.
Publicado: (2019)

SARS-CoV-2-associated cold agglutinin disease: a report of two cases
por: Huscenot, Tessa, et al.
Publicado: (2020)

Perioperative management of a patient with severe cold agglutinin disease by using multimodal warming measures
por: Koyama, Yukihide, et al.
Publicado: (2021)

Increased Fibrinolysis as a Specific Marker of Poor Outcome After Cardiac Arrest
por: Buchtele, Nina, et al.
Publicado: (2018)

Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence
por: Buchtele, Nina, et al.
Publicado: (2018)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

A COLD CASE OF COVID-19-INDUCED COLD AGGLUTININ DISEASE
por: DOUEN, AARON, et al.
Publicado: (2021)

Cold Agglutinins and Cryoglobulins Associate With Clinical and Laboratory Parameters of Cold Urticaria
por: Bizjak, Mojca, et al.
Publicado: (2021)

Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis
por: Jorda, Anselm, et al.
Publicado: (2021)

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
por: Broome, Catherine M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cc5leodedeg2b5dqhi56j6qnvh